Page last updated: 2024-09-05

lenalidomide and Atypical Chronic Myeloid Leukemia

lenalidomide has been researched along with Atypical Chronic Myeloid Leukemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biemond, BJ1

Other Studies

1 other study(ies) available for lenalidomide and Atypical Chronic Myeloid Leukemia

ArticleYear
Treatment considerations for primary myelofibrosis.
    The Netherlands journal of medicine, 2010, Volume: 68, Issue:1

    Topics: Anemia; Angiogenesis Inhibitors; Antineoplastic Agents; Humans; Lenalidomide; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Neovascularization, Pathologic; Primary Myelofibrosis; Prognosis; Risk Factors; Thalidomide

2010
chemdatabank.com